Medtech Startup Xenter Bags $58.25M in Series B Financing

The company will use the funding to support its product launch, advance its technology, expand manufacturing, complete clinical and regulatory work, and grow its integrated TechMed platform.

The funding round included support from existing investors, leading family offices, and healthcare investors who believe in Xenter’s vision to transform how healthcare data is collected, connected, and used by hospitals and doctors.

Read More:Cybersecurity Startup Beacon Security Scores $13M in Seed Funding

"The closing of Series B strongly validates Xenter's wireless Physical Intelligence platform and enables the first commercial launch of our diagnostics business unit and the initiation of planned clinical testing of the Guru™ dual sensor physiology guidewire in Transcatheter Aortic Valve Replacement (TAVR) procedures," said Richard J. Linder, Founder, Chairman and Chief Executive Officer of Xenter.

Richard J. Linder continued, "Healthcare has historically been built around disconnected devices and computers on wheels with fragmented information systems. Xenter is building an integrated intelligence platform designed to connect medical devices, diagnostics, digital health, and AI into a seamless ecosystem that enables better clinical decision-making while continually ensuring patients control their healthcare data."

About Xenter

Founded in 2020 by Richard J. Linder, Xenter is a TechMed company developing new technologies that connect healthcare data across the entire patient care journey. The company combines medical devices, data infrastructure, and clinical AI to turn real-time clinical data into valuable insights that help improve healthcare.

Read More:Fintech Startup Alpaca Scores $135M in Funding Led by Peak XV